Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian Kolodzik

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Chemical Information and Modeling|July 12, 2012
Unique ring families: a chemically meaningful description of molecular ring topologiesAdrian Kolodzik, Sascha Urbaczek, Matthias Rarey
Journal of Chemical Information and Modeling|February 19, 2014
The valence state combination model: a generic framework for handling tautomers and protonation statesSascha Urbaczek, Adrian Kolodzik, Matthias Rarey
Journal of Chemical Information and Modeling|November 27, 2012
Reading PDB: perception of molecules from 3D atomic coordinatesSascha Urbaczek, Adrian Kolodzik, Inken Groth, et al.
Medchemcomm|August 16, 2018
PAIN-less identification and evaluation of small molecule inhibitors against protein tyrosine phosphatase 1BHamid R Nasiri, Philipp Mracek, Steffen K Grimm, et al.
Biochemistry|March 5, 2010
Mycobacterium tuberculosis Rv0899 adopts a mixed alpha/beta-structure and does not form a transmembrane beta-barrelPeter Teriete, Yong Yao, Adrian Kolodzik, et al.
Chemmedchem|March 12, 2014
In silico design, synthesis, and screening of novel deoxyhypusine synthase inhibitors targeting HIV-1 replicationMarcus Schroeder, Adrian Kolodzik, Katharina Pfaff, et al.
Journal of Chemical Information and Modeling|November 10, 2011
NAOMI: on the almost trivial task of reading molecules from different file formatsSascha Urbaczek, Adrian Kolodzik, J Robert Fischer, et al.
Archiv Der Pharmazie|January 4, 2016
Linker-Region Modified Derivatives of the Deoxyhypusine Synthase Inhibitor CNI-1493 Suppress HIV-1 ReplicationMarcus Schröder, Adrian Kolodzik, Björn Windshügel, et al.
Investigational New Drugs|March 15, 2012
Evaluation of deoxyhypusine synthase inhibitors targeting BCR-ABL positive leukemiasPatrick Ziegler, Tuhama Chahoud, Thomas Wilhelm, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Chemical Information and Modeling|July 12, 2012
Unique ring families: a chemically meaningful description of molecular ring topologiesAdrian Kolodzik, Sascha Urbaczek, Matthias Rarey
Journal of Chemical Information and Modeling|February 19, 2014
The valence state combination model: a generic framework for handling tautomers and protonation statesSascha Urbaczek, Adrian Kolodzik, Matthias Rarey
Journal of Chemical Information and Modeling|November 27, 2012
Reading PDB: perception of molecules from 3D atomic coordinatesSascha Urbaczek, Adrian Kolodzik, Inken Groth, et al.
Medchemcomm|August 16, 2018
PAIN-less identification and evaluation of small molecule inhibitors against protein tyrosine phosphatase 1BHamid R Nasiri, Philipp Mracek, Steffen K Grimm, et al.
Biochemistry|March 5, 2010
Mycobacterium tuberculosis Rv0899 adopts a mixed alpha/beta-structure and does not form a transmembrane beta-barrelPeter Teriete, Yong Yao, Adrian Kolodzik, et al.
Chemmedchem|March 12, 2014
In silico design, synthesis, and screening of novel deoxyhypusine synthase inhibitors targeting HIV-1 replicationMarcus Schroeder, Adrian Kolodzik, Katharina Pfaff, et al.
Journal of Chemical Information and Modeling|November 10, 2011
NAOMI: on the almost trivial task of reading molecules from different file formatsSascha Urbaczek, Adrian Kolodzik, J Robert Fischer, et al.
Archiv Der Pharmazie|January 4, 2016
Linker-Region Modified Derivatives of the Deoxyhypusine Synthase Inhibitor CNI-1493 Suppress HIV-1 ReplicationMarcus Schröder, Adrian Kolodzik, Björn Windshügel, et al.
Investigational New Drugs|March 15, 2012
Evaluation of deoxyhypusine synthase inhibitors targeting BCR-ABL positive leukemiasPatrick Ziegler, Tuhama Chahoud, Thomas Wilhelm, et al.
Pageof 1